Floatz logo

Clofarabine

HER2 Positive Gastric Cancer

Triumvira Immunologics, Inc.Small moleculePhase 1/2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the HER2 Positive Gastric Cancer cohort.

Asset / SponsorPhaseRating
Fludarabine
Dispatch Biotherapeutics
Phase 1/2B
ANTI-HER2 ANTIBODY-DRUG CONJUGATE A166
Klus Pharma Inc.
Phase 1/2CCC
TAC-engineered T cells TAC01-HER2
Triumvira Immunologics, Inc.
Phase 1/2CCC
Bendamustine
Triumvira Immunologics, Inc.
Phase 1/2CCC
Fate-Nk100
Fate Therapeutics
Phase 1CC

Same molecule, other indications

Clofarabine is also rated in:

acute myeloid leukemia with 11q23 abnormalitiesDormant
BB
Indicative ·
70 / 100
View asset →
acute myeloid leukemia, del(5q31-q32)Dormant
BB
Indicative ·
70 / 100
View asset →
disease related to hematopoietic stem cell transplantDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →